We report that the expression of murine or human mutant p53 proteins i
n cells with no endogenous p53 proteins confers new or additional phen
otypes upon these cells. Mutant p53 proteins expressed in cell lines l
acking p53 resulted in either enhanced tumorigenic potential in nude m
ice ((10)3 cells) or enhanced plating efficiency in agar cell culture
(human SAOS-2 cells). Also, mutant human p53 alleles, unlike the wild-
type p53 protein, could also enhance the expression of a test gene reg
ulated by the multi-drug resistance enhancer-promoter element. These d
ata demonstrate a gain of function associated with p53 mutations in ad
dition to the loss of function shown previously to be associated with
mutations in this tumour suppressor gene.